home / stock / acst / acst quote
Last: | $2.96 |
---|---|
Change Percent: | 1.98% |
Open: | $2.97 |
Close: | $2.96 |
High: | $3.0842 |
Low: | $2.875 |
Volume: | 13,180 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.96 | $2.97 | $2.96 | $3.0842 | $2.875 | 13,180 | 05-03-2024 |
$3.03 | $2.85 | $3.03 | $3.1132 | $2.85 | 16,573 | 05-02-2024 |
$2.8501 | $2.77 | $2.8501 | $2.93 | $2.7 | 4,500 | 05-01-2024 |
$2.78 | $2.7 | $2.78 | $3.05 | $2.65 | 10,392 | 04-30-2024 |
$2.68 | $2.84 | $2.68 | $2.84 | $2.66 | 6,916 | 04-29-2024 |
$2.9 | $2.798 | $2.9 | $3.1252 | $2.7701 | 3,831 | 04-26-2024 |
$2.9285 | $2.86 | $2.9285 | $2.93 | $2.86 | 2,583 | 04-25-2024 |
$2.9 | $2.871 | $2.9 | $3.16 | $2.871 | 8,395 | 04-24-2024 |
$2.88 | $2.85 | $2.88 | $2.88 | $2.85 | 4,477 | 04-23-2024 |
$2.85 | $2.81 | $2.85 | $2.9123 | $2.81 | 9,896 | 04-22-2024 |
$2.87 | $3.07 | $2.87 | $3.08 | $2.87 | 19,865 | 04-19-2024 |
$3.07 | $3.17 | $3.07 | $3.17 | $3.06 | 9,713 | 04-18-2024 |
$3.1899 | $3.31 | $3.1899 | $3.31 | $3.16 | 16,859 | 04-17-2024 |
$3.35 | $3.33 | $3.35 | $3.39 | $3.3 | 7,390 | 04-16-2024 |
$3.36 | $3.41 | $3.36 | $3.41 | $3.32 | 21,644 | 04-15-2024 |
$3.405 | $3.34 | $3.405 | $3.415 | $3.305 | 5,891 | 04-12-2024 |
$3.4 | $3.38 | $3.4 | $3.4 | $3.3 | 26,875 | 04-11-2024 |
$3.4 | $3.4 | $3.4 | $3.4 | $3.26 | 21,308 | 04-10-2024 |
$3.4 | $3.41 | $3.4 | $3.41 | $3.32 | 16,990 | 04-09-2024 |
$3.4 | $3.4 | $3.4 | $3.43 | $3.32 | 9,123 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Projected Cash Runway Extends into Second Calendar Quarter 2026, Well Beyond Potential 1H 2025 Submission of GTX-104 New Drug Application (NDA) Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial Continues, On Track for NDA Submission Timeline Poster Highlighting the STRIVE-ON...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (Acasti or the Company), a late-stage, biopharma company adv...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (...